ATE218861T1 - Vasculäre hypertrophicsuppressor - Google Patents

Vasculäre hypertrophicsuppressor

Info

Publication number
ATE218861T1
ATE218861T1 AT94102790T AT94102790T ATE218861T1 AT E218861 T1 ATE218861 T1 AT E218861T1 AT 94102790 T AT94102790 T AT 94102790T AT 94102790 T AT94102790 T AT 94102790T AT E218861 T1 ATE218861 T1 AT E218861T1
Authority
AT
Austria
Prior art keywords
optionally substituted
ring
hetero
residue
suppressor
Prior art date
Application number
AT94102790T
Other languages
English (en)
Inventor
Kohei Nishikawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE218861T1 publication Critical patent/ATE218861T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94102790T 1993-02-25 1994-02-24 Vasculäre hypertrophicsuppressor ATE218861T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3663093 1993-02-25

Publications (1)

Publication Number Publication Date
ATE218861T1 true ATE218861T1 (de) 2002-06-15

Family

ID=12475158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94102790T ATE218861T1 (de) 1993-02-25 1994-02-24 Vasculäre hypertrophicsuppressor

Country Status (6)

Country Link
US (2) US5508297A (de)
EP (1) EP0612523B1 (de)
AT (1) ATE218861T1 (de)
CA (1) CA2115985A1 (de)
DE (1) DE69430766T2 (de)
ES (1) ES2173895T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
PL356422A1 (en) * 2000-02-18 2004-06-28 Takeda Chemical Industries, Ltd. Tnf-alpha inhibitors
CA2420055C (en) * 2000-08-25 2010-06-01 Takeda Chemical Industries, Ltd. Fibrinogen-lowering agent
US7546089B2 (en) * 2004-12-23 2009-06-09 Triquint Semiconductor, Inc. Switchable directional coupler for use with RF devices
AR065850A1 (es) * 2007-03-28 2009-07-08 Takeda Pharmaceutical Composicion farmaceutica solida que comprende un derivado de benzimidazol-7-carboxilato y un agente de control de ph
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0400835A1 (de) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituierte Benzimidazole als Angiotensin II-Hemmer
DE69013607T2 (de) * 1989-08-02 1995-03-02 Takeda Chemical Industries Ltd Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
EP0434038A1 (de) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Kondensierte Imidazolderivate, ihre Herstellung und Verwendung
US5162326A (en) * 1990-02-15 1992-11-10 Takeda Chemical Industries, Ltd. Pyrimidinedione derivatives, their production and use
US5284661A (en) * 1990-02-22 1994-02-08 Takeda Chemical Industries, Ltd. Fused thiophene derivatives, their production and use
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5166143A (en) * 1990-05-31 1992-11-24 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
ES2121773T3 (es) * 1990-06-08 1998-12-16 Hoechst Marion Roussel Inc Derivados de bencimidazol, su procedimiento de preparacion, productos intermedios, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
AU636066B2 (en) * 1990-10-30 1993-04-08 Takeda Chemical Industries Ltd. Thienoimidazole derivatives, their production and use
GB9027200D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
DE4225756A1 (de) * 1992-01-22 1994-03-10 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
TW274551B (de) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
US5210211A (en) * 1991-06-21 1993-05-11 Warner-Lambert Company 4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
ATE264323T1 (de) * 1992-09-14 2004-04-15 Takeda Chemical Industries Ltd Heterocyclische verbindungen und ihre verwendung als angiotensin ii antagonisten
EP0603712B1 (de) * 1992-12-22 2001-08-16 Takeda Chemical Industries, Ltd. Heterocyclische Verbindungen mit Angiotensin-II-antagonistischer Wirkung und ihre Anwendung

Also Published As

Publication number Publication date
US5508297A (en) 1996-04-16
DE69430766T2 (de) 2003-02-06
DE69430766D1 (de) 2002-07-18
CA2115985A1 (en) 1994-08-26
EP0612523B1 (de) 2002-06-12
ES2173895T3 (es) 2002-11-01
EP0612523A1 (de) 1994-08-31
US5736561A (en) 1998-04-07

Similar Documents

Publication Publication Date Title
HUP0002476A2 (hu) Aminvegyületek, előállításuk és alkalmazásuk
ATE327230T1 (de) Piperidinverbindungen und diese enthaltenden medikamente
PT1063228E (pt) Derivados de cicloalcenos processo para a sua preparacao e utilizacao
DE69407409D1 (de) Azolylamin-derivat
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
FI944417A0 (fi) Atsoliyhdisteet, niiden valmistus ja käyttö
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
EP0293771A3 (de) Cephalosporinverbindungen und sie enthaltende pharmazeutische Präparate
DE69430766D1 (de) Vasculäre Hypertrophicsuppressor
ATE203020T1 (de) Schwefel enthaltende heterocyclische verbindungen
EP0648760A3 (de) Triazin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
AP2000002008A0 (en) Tetrahydroquinoline derivatives as glycine antagonists.
DE69423529D1 (de) Arzneizusammensetzungen enthaltend Argatrobananaloge
EP0603712A3 (en) Heterocyclic compounds having angiotensin ii antagonistic activity and use thereof.
MY108849A (en) Novel compound
DE69416683D1 (de) Benzolactam-derivate
TW259785B (en) Chemical compounds
ATE168679T1 (de) Neue tetracyclische verbindungen
DE69014930D1 (de) Aralkylamin-Verbindungen.
DE60116656D1 (de) Verfahren zur Herstellung Antibakterieller Verbindungen vom Carbapenem-Typ
DE69016266D1 (de) Aminoketonverbindungen.
GB9104833D0 (en) Heterocyclic compounds
ES2053792T3 (es) Procedimiento de preparacion de un compuesto oximino de tiazol.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties